The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of treatment delays with an unfavorable outcome in patients with localized Ewing sarcoma: A retrospective analysis of data from the GPOH Euro-E.W.I.N.G.99 trial.
 
Uta Dirksen
Consulting or Advisory Role - Ipsen; Lilly (Inst)
 
Andreas Ranft
No Relationships to Disclose
 
Daniel Baumhoer
No Relationships to Disclose
 
Henk van den Berg
No Relationships to Disclose
 
Bénédicte Brichard
No Relationships to Disclose
 
Hans-Theodor Eich
No Relationships to Disclose
 
Hans Gelderblom
Research Funding - Daiichi (Inst); Deciphera (Inst); Ipsen (Inst); Novartis (Inst)
 
Jendrik Hardes
No Relationships to Disclose
 
Wolfgang Hartmann
Travel, Accommodations, Expenses - Menarini Silicon Biosystems
 
Heribert Juergens
No Relationships to Disclose
 
Attila Kollar
Honoraria - Ipsen; Lilly; PharmaMar
Consulting or Advisory Role - Eisai; Lilly; Novartis; PharmaMar
Travel, Accommodations, Expenses - Amgen; Ipsen; Lilly; Novartis; PharmaMar
 
Jarmila Kruseova
No Relationships to Disclose
 
Thomas Kuehne
Consulting or Advisory Role - Amgen; Novartis; SOBI; UCB
Research Funding - Amgen (Inst)
Expert Testimony - Amgen
Travel, Accommodations, Expenses - Bayer; CSL Behring; Novartis; Novo Nordisk; SOBI
 
Ruth Lydia Ladenstein
Honoraria - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma
Consulting or Advisory Role - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma (Inst)
Research Funding - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Expert Testimony - Apeiron Biologics; EUSA Pharma
Travel, Accommodations, Expenses - Apeiron Biologics; EUSA Pharma
 
Andreas Leithner
No Relationships to Disclose
 
Arne Streitbuerger
No Relationships to Disclose
 
Beate Timmermann
No Relationships to Disclose
 
Per-Ulf Tunn
No Relationships to Disclose
 
Dimosthenis Andreou
No Relationships to Disclose